Published in




Key Takeaways:

  • We did a deep dive and wrote a 47-page white paper on psychedelics, covering the history, science, and business opportunity.
  • I learned a ton about the world of psychedelics, one that I knew absolutely nothing about previously. Now, I feel educated enough to have an opinion on both. Plus, it was a cool overlap in coursework between my Cyborg Psychology class and Race, Drugs, and Drug Policy class.
  • Gained FASCINATING insight into the motivations and practices of current psychedelic users
  • Working some PM muscles (similar to building WellPower or currently working on tech for radiologists) by researching a user with whom you do not identify and designing a product for them.

The Problem


No current solution addresses a need for both users (virtual guide, insight into experience) + researchers (unexplored metrics + data, prev. research = qualitative + occurs after a trip)


The Substances

Chemical Composition

History of Psychedelics

The Experience

User Segmentation

Key findings from our user research

The Product

How It Works

User Journey for V1 and V2

Version 1

Mock Up of Version 1

Version 2

Mock Up of Version 2

Core Features

Uploading External Information

Involve Your Body

  • Keep tabs on your body and biometrics before, during, and after a trip
  • Engage your body and mind in your reflection

Users opt-in to sharing their health data with researchers

Business Plan


Health + Mental Illness

Market Size

Our share of the market is the 1.31 million users between 18–25 who use psychedelics for mental health. Our serviceable addressable market is the 30 million psychedelic users, including recreational users, in the United States. Finally, our total available market is valued at more than $192 million, for the market of mindfulness apps. Ideally, our users will use our app when using psychedelics and when “sober.” (all sources from this paragraph are linked in the pitch deck)

Business Model

Value Proposition

Go To Market

Competitive Landscape

Technological Precedence and Inspiration

Migraine Buddy


  • Vice clauses prevent many VCs from investing in anything related to psychedelics.
  • I think the legality of these substances is a huge blocker to the success of this sort of application.
  • I really enjoyed exploring this space and gained a lot of energy from learning about something totally new, I’m not going to try psychedelics anytime soon. It’s definitely possible, but more challenging, to build a consumer app for a user with whom you do not identify with.

The white paper, presentation, and idea for PsychU was developed by Bevin Benson, Naomi Shifrin, Ayushi Sinha, and Kara Steele.



I’m starting Retrospectare to share big visions, exploratory findings, blockers + why I chose not to pursue this particular project, surprises and discoveries, and incredible people I riffed with and learned from along the way. Just like your weekly retro scrum, for big ideas.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Ayushi Sinha

MBA @ Harvard, co-founder @ | Princeton CS, investor @ Bain Capital Ventures, Microsoft